Carregant...
Novel RNA-targeted therapies for hereditary ATTR amyloidosis and their impact on the autonomic nervous system
PURPOSE: Transthyretin-mediated hereditary amyloidosis (hATTR amyloidosis) is a multisystemic disease with heterogeneous clinical presentation. Hallmarks of the disease are sensory-motor and autonomic neuropathy and cardiomyopathy. Two disease-modifying drugs, inotersen (an antisense oligonucleotide...
Guardat en:
| Publicat a: | Clin Auton Res |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763402/ https://ncbi.nlm.nih.gov/pubmed/31399774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10286-019-00626-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|